vimarsana.com

Page 192 - நோய் எதிர்ப்பு சக்தி டோவர்டீ நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Country - Kiwifruit edition

The Country - Kiwifruit edition Quick Read The Country Today on The Country Jamie Mackay caught up with Kiwifruit Claim Committee chairman, John Cameron, who took MPI to court over allowing the plant disease Psa to enter New Zealand. On with the show: David Seymour: The Act Party leader said it was only a matter of time before an outbreak forced another lockdown . Advertisement John Cameron: Is a Bay of Plenty kiwifruit grower and chairman of the Kiwifruit Claim Committee who took MPI to court over allowing the plant disease Psa to enter the country. The near decade-long dispute was finally settled on Friday when the Government agreed to pay $40 million in compensation, much less than the $450 million initially sought.

Shilpa Medicare declines for 3rd day

Shilpa Medicare fell 1.25% to Rs 424.30, extending losses for third day. The stock has declined 1.6% in three sessions from its recent closing high of Rs 431 on 10 February 2021. In the past six months, the stock has declined by 31.99% while the benchmark Sensex has added 37.61% during the same period. In a BSE filing made during market hours today, Shilpa Medicare announced the launch of Sunitinib capsules, under the brand name SUNISHIL in India. The Sunitinib capsules has been launched in three strengths of 12.5 mg, 25 mg and 50 mg Sunitinib malate is a novel oral multi targeted tyrosine kinase inhibitor with antitumor and antiangiogenic activities. The drug is indicated for the treatment of G.I. Stromal tumor after disease progression on or intolerance to Imatinib mesylate, advanced Renal Cell Carcinoma, and for the treatment of Unresectable or Metastatic Welldifferentiated Pancreatic Neuroendocrine Tumors with Disease Progression in adults.

CAL THOMAS: Andrew Cuomo s deadly lie

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.